Search Results - "Krskova, Lenka"

Refine Results
  1. 1
  2. 2
  3. 3

    Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas by Lassaletta, Alvaro, Zapotocky, Michal, Mistry, Matthew, Ramaswamy, Vijay, Honnorat, Marion, Krishnatry, Rahul, Guerreiro Stucklin, Ana, Zhukova, Nataliya, Arnoldo, Anthony, Ryall, Scott, Ling, Catriona, McKeown, Tara, Loukides, Jim, Cruz, Ofelia, de Torres, Carmen, Ho, Cheng-Ying, Packer, Roger J, Tatevossian, Ruth, Qaddoumi, Ibrahim, Harreld, Julie H, Dalton, James D, Mulcahy-Levy, Jean, Foreman, Nicholas, Karajannis, Matthias A, Wang, Shiyang, Snuderl, Matija, Nageswara Rao, Amulya, Giannini, Caterina, Kieran, Mark, Ligon, Keith L, Garre, Maria Luisa, Nozza, Paolo, Mascelli, Samantha, Raso, Alessandro, Mueller, Sabine, Nicolaides, Theodore, Silva, Karen, Perbet, Romain, Vasiljevic, Alexandre, Faure Conter, Cécile, Frappaz, Didier, Leary, Sarah, Crane, Courtney, Chan, Aden, Ng, Ho-Keung, Shi, Zhi-Feng, Mao, Ying, Finch, Elizabeth, Eisenstat, David, Wilson, Bev, Carret, Anne Sophie, Hauser, Peter, Sumerauer, David, Krskova, Lenka, Larouche, Valerie, Fleming, Adam, Zelcer, Shayna, Jabado, Nada, Rutka, James T, Dirks, Peter, Taylor, Michael D, Chen, Shiyi, Bartels, Ute, Huang, Annie, Ellison, David W, Bouffet, Eric, Hawkins, Cynthia, Tabori, Uri

    Published in Journal of clinical oncology (01-09-2017)
    “…Purpose BRAF V600E is a potentially highly targetable mutation detected in a subset of pediatric low-grade gliomas (PLGGs). Its biologic and clinical effect…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell Lines by Feriancikova, Barbara, Feglarova, Tereza, Krskova, Lenka, Eckschlager, Tomas, Vicha, Ales, Hrabeta, Jan

    “…Neuroblastoma (NBL) is the most common extracranial childhood malignant tumor and represents a major cause of cancer-related deaths in infants. amplification…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Unusual case of inflammatory rhabdomyoblastic tumor in a pediatric patient by Krsková, Lenka, Šípalová, Barbora, Balko, Jan, Zimová, Simona, Voříšková, Dagmar, Brož, Petr, Kodet, Roman, Vícha, Aleš

    Published in Pathology, research and practice (01-06-2023)
    “…Inflammatory rhabdomyoblastic tumor (IRMT) is a rare, recently described skeletal muscle neoplasm of uncertain malignant potential. We report an unusual tumor…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Patient with composite haemangioendothelioma containing angiosarcoma-like areas in the setting of congenital lymphoedema mimicking Stewart-Treves syndrome: a case report by Balko, Jan, Ozaniak, Andrej, Krskova, Lenka, Strizova, Zuzana, Lischke, Robert, Zamecnik, Josef

    Published in Diagnostic pathology (22-06-2023)
    “…Composite haemangioendothelioma is a rare vascular neoplasm with indolent to intermediate malignant potential. Diagnosis of this disease relays on…”
    Get full text
    Journal Article
  11. 11

    Mazabraud's syndrome: A case report supported by molecular studies and review of the literature by Kašpar, Ludvík, Balko, Jan, Strnadová, Martina, Krsková, Lenka, Máška, David, Zámečník, Josef

    Published in Bone Reports (01-06-2023)
    “…Mazabraud's syndrome represents rare benign disorder characterized by simultaneous occurrence of fibrous dysplasia of bone and intramuscular myxomas within…”
    Get full text
    Journal Article
  12. 12

    Clinical and molecular study of radiation-induced gliomas by Trkova, Katerina, Sumerauer, David, Bubenikova, Adela, Krskova, Lenka, Vicha, Ales, Koblizek, Miroslav, Zamecnik, Josef, Jurasek, Bruno, Kyncl, Martin, Malinova, Bela, Ondrova, Barbora, Jones, David T. W., Sill, Martin, Strnadova, Martina, Stolova, Lucie, Misove, Adela, Benes, Vladimir, Zapotocky, Michal

    Published in Scientific reports (07-02-2024)
    “…In this study, we provide a comprehensive clinical and molecular biological characterization of radiation-induced gliomas (RIG), including a risk assessment…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    A novel quantitative PCR of proliferation markers (Ki-67, topoisomerase IIα, and TPX2): an immunohistochemical correlation, testing, and optimizing for mantle cell lymphoma by Brizova, Helena, Kalinova, Marketa, Krskova, Lenka, Mrhalova, Marcela, Kodet, Roman

    “…A clinical course of patients with mantle cell lymphoma (MCL) is aggressive, and the disease is rarely curable. Proliferation rate is the most important…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20